BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee JY, Chang J. Universal vaccine against respiratory syncytial virus A and B subtypes. PLoS One 2017;12:e0175384. [PMID: 28384263 DOI: 10.1371/journal.pone.0175384] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Mayburd A. Cross-testing of direct-action antivirals, universal vaccines, or search for host-level antivirals: what will sooner lead to a generic capability to combat the emerging viral pandemics? Expert Rev Anti Infect Ther 2021;:1-5. [PMID: 34719314 DOI: 10.1080/14787210.2022.2000859] [Reference Citation Analysis]
2 Pusch E, Renz H, Skevaki C. Respiratory virus-induced heterologous immunity: Part of the problem or part of the solution? Allergo J Int 2018;27:79-96. [PMID: 32226720 DOI: 10.1007/s40629-018-0056-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
3 Lee JY, Chang J. Recombinant baculovirus-based vaccine expressing M2 protein induces protective CD8+ T-cell immunity against respiratory syncytial virus infection. J Microbiol 2017;55:900-8. [PMID: 29076066 DOI: 10.1007/s12275-017-7306-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
4 Clark CM, Guerrero-Plata A. Respiratory Syncytial Virus Vaccine Approaches: a Current Overview. Curr Clin Microbiol Rep 2017;4:202-7. [PMID: 30009126 DOI: 10.1007/s40588-017-0074-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
5 Tripp RA, Power UF, Openshaw PJM, Kauvar LM. Respiratory Syncytial Virus: Targeting the G Protein Provides a New Approach for an Old Problem. J Virol 2018;92:e01302-17. [PMID: 29118126 DOI: 10.1128/JVI.01302-17] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
6 Lee YJ, Lee JY, Jang YH, Seo SU, Chang J, Seong BL. Non-specific Effect of Vaccines: Immediate Protection against Respiratory Syncytial Virus Infection by a Live Attenuated Influenza Vaccine. Front Microbiol 2018;9:83. [PMID: 29445364 DOI: 10.3389/fmicb.2018.00083] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
7 Pusch E, Renz H, Skevaki C. Respiratory virus-induced heterologous immunity: Part of the problem or part of the solution? Allergo J 2018;27:28-45. [PMID: 32300267 DOI: 10.1007/s15007-018-1580-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
8 Jo YM, Kim J, Chang J. Vaccine containing G protein fragment and recombinant baculovirus expressing M2 protein induces protective immunity to respiratory syncytial virus. Clin Exp Vaccine Res 2019;8:43-53. [PMID: 30775350 DOI: 10.7774/cevr.2019.8.1.43] [Reference Citation Analysis]
9 Sampayo-Escobar V, Green R, Cheung MB, Bedi R, Mohapatra S, Mohapatra SS. Osteopontin plays a pivotal role in increasing severity of respiratory syncytial virus infection. PLoS One 2018;13:e0192709. [PMID: 29677209 DOI: 10.1371/journal.pone.0192709] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
10 Kim YS, Son A, Kim J, Kwon SB, Kim MH, Kim P, Kim J, Byun YH, Sung J, Lee J, Yu JE, Park C, Kim YS, Cho NH, Chang J, Seong BL. Chaperna-Mediated Assembly of Ferritin-Based Middle East Respiratory Syndrome-Coronavirus Nanoparticles. Front Immunol 2018;9:1093. [PMID: 29868035 DOI: 10.3389/fimmu.2018.01093] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 12.3] [Reference Citation Analysis]
11 Borochova K, Niespodziana K, Stenberg Hammar K, van Hage M, Hedlin G, Söderhäll C, Focke-Tejkl M, Valenta R. Features of the Human Antibody Response against the Respiratory Syncytial Virus Surface Glycoprotein G. Vaccines (Basel) 2020;8:E337. [PMID: 32630611 DOI: 10.3390/vaccines8020337] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Soto JA, Stephens LM, Waldstein KA, Canedo-Marroquín G, Varga SM, Kalergis AM. Current Insights in the Development of Efficacious Vaccines Against RSV. Front Immunol 2020;11:1507. [PMID: 32765520 DOI: 10.3389/fimmu.2020.01507] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]